Azadeh Golipour Ph.D. Net Worth

The estimated Net Worth of Azadeh Golipour is at least $95.3 Thousand dollars as of 1 February 2024. Ms Golipour owns over 37,334 units of AvroBio Inc stock worth over $95,346 and over the last 2 years she sold AVRO stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Ms D AVRO stock SEC Form 4 insiders trading

Ms has made over 1 trades of the AvroBio Inc stock since 2024, according to the Form 4 filled with the SEC. Most recently she exercised 37,334 units of AVRO stock worth $52,268 on 1 February 2024.

The largest trade she's ever made was exercising 37,334 units of AvroBio Inc stock on 1 February 2024 worth over $52,268. On average, Ms trades about 9,334 units every 0 days since 2022. As of 1 February 2024 she still owns at least 68,104 units of AvroBio Inc stock.

You can see the complete history of Ms Golipour stock trades at the bottom of the page.

Ms. Azadeh Golipour Ph.D. biography

Azadeh Golipour Ph.D. is the Chief Technology Officer at AvroBio Inc.

What's Ms D's mailing address?

Azadeh's mailing address filed with the SEC is C/O AVROBIO, INC., 100 TECHNOLOGY SQUARE, 6TH FLOOR, CAMBRIDGE, MA, 02139.

Insiders trading at AvroBio Inc

Over the last 6 years, insiders at AvroBio Inc have traded over $3,066,308 worth of AvroBio Inc stock and bought 2,395,057 units worth $31,037,133 . The most active insiders traders include Braden Michael Leonard, Bruce Booth, and Venture Fund X, L.P.Atlas V.... On average, AvroBio Inc executives and independent directors trade stock every 102 days with the average trade being worth of $206,675. The most recent stock trade was executed by Braden Michael Leonard on 13 May 2024, trading 766,635 units of AVRO stock currently worth $973,626.

What does AvroBio Inc do?

clinical stage company focused on delivering step-change cell & gene therapies targeting cancer and rare disease.

Complete history of Ms Golipour stock trades at AvroBio Inc

AvroBio Inc executives and stock owners

AvroBio Inc executives and other stock owners filed with the SEC include:

• Birgitte Volck,
  President - Research & Development
• Erik Ostrowski,
  Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer, Treasurer
• Geoff MacKay,
  President, Chief Executive Officer, Director
• Steven Avruch,
  Secretary, Chief Legal Officer
• Geoff MacKay BSc,
  Co- Founder, Pres, CEO & Director
• Geoff MacKay,
  Co- Founder, Pres, CEO & Director
• Erik Ostrowski M.B.A.,
  CFO & Treasurer
• Steven N. Avruch J.D.,
  Chief Legal Officer & Sec.
• Philip Vickers,
  Independent Director
• Bruce Booth,
  Independent Chairman of the Board
• Christopher Paige,
  Independent Director
• Phillip Donenberg,
  Independent Director
• Annalisa Jenkins,
  Independent Director
• Ian Clark,
  Independent Director
• Gail Farfel,
  Director
• Kim Raineri,
  Chief Manufacturing and Technology Officer
• Chris Brinzey,
  IR Contact Officer
• Deanna Petersen,
  Chief Business Officer
• Dr. Essra Ridha FFPM, M.D.,
  Chief Medical Officer
• Andreas Kouri,
  Sr. VP of Global Supply Chain & External Manufacturing
• Azadeh Golipour Ph.D.,
  Chief Technology Officer
• Deanna M. Petersen MBA,
  Chief Bus. Officer
• Dr. Christopher Mason FMEDSCI, FRCS, M.D., Ph.D.,
  Chief Scientific Officer
• Dr. Christopher Mason FMEDSCI, M.D., Ph.D., FRCS,
  Chief Scientific Officer
• Deanna M. Petersen M.B.A., MBA,
  Chief Bus. Officer
• Georgette Verdin,
  Chief HR Officer
• Monique Da Silva,
  Sr. VP of Corp. Communications
• Dr. Christopher Mason,
  Chief Scientific Officer
• Kim Raineri M.B.A.,
  Chief Manufacturing & Technology Officer
• Matthew Arnold,
  Head of Operations
• Jeffrey Medin Ph.D.,
  Scientific Founder
• Venture Fund X, L.P.Atlas V...,
  
• Lifesciences Iii, L.P.Claru...,
  
• Scott Requadt,
  Director
• Vi, Llcsv Life Sciences Fun...,
  
• Katina Dorton,
  Chief Financial Officer
• Nerissa Kreher,
  Chief Medical Officer
• Venture Associates X, L.P. ...,
  10% owner
• Lifesciences Iii, L.P.Claru...,
  
• Diana Escolar,
  Chief Medical Officer
• Christopher Mason,
  Chief Scientific Officer
• Essra Ridha,
  Chief Medical Officer
• Azadeh Golipour,
  Chief Technology Officer
• Braden Michael Leonard,